Skip to main content

Calciquid Side Effects

Generic name: calcium glubionate

Medically reviewed by Last updated on Mar 13, 2023.

Note: This document contains side effect information about calcium glubionate. Some dosage forms listed on this page may not apply to the brand name Calciquid.

Applies to calcium glubionate: oral syrup.


Do not take calcium glubionate or antacids containing calcium without first talking to your doctor if you take other medications. Aluminum can decrease the effects of many other medicines by binding to them or by changing the acidity of the stomach or the urine.

Take calcium with meals to increase its absorption by the body.

Stop taking calcium glubionate (the active ingredient contained in Calciquid) and seek emergency medical attention if you experience a rare allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take calcium glubionate and notify your doctor if you experience

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.

For Healthcare Professionals

Applies to calcium glubionate: oral syrup.


Metabolic side effects have included hypercalcemia and hypercalciuria.[Ref]

When calcium is administered for prolonged periods, hypercalcemia and hypercalciuria may result. This is more likely in patients with hypoparathyroidism who are also receiving large amounts of milk.[Ref]


Genitourinary side effects have rarely included hypercalciuria and the development of calcium nephrolithiasis.[Ref]

Prolonged administration can result in hypercalciuria and the development of calcium nephrolithiasis in some cases, particularly when in the presence of loop diuretics.[Ref]


Gastrointestinal side effects have been reported rarely. They have included nausea and constipation.[Ref]


1. (2001) "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation

2. Fordtran JS (1968) "Acid rebound." N Engl J Med, 279, p. 900-5

3. Edelson GW, Kleerekoper M (1995) "Hypercalcemic crisis." Med Clin North Am, 79, p. 79-92

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.